Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03627806 · ClinicalTrials.gov registry record
FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 104,308
- Enrollment target
NCT03627806: Completed study, sponsored by University of Miami.
NCT03627806 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 104,308 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03627806 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 104,308 participants
- Enrollment target
Study Summary
In this study, FL-PR Stroke Registry will be used to determine novel data on disparities in stroke care and outcomes for patients with Atrial Fibrillation (AF) in 'real life' hospital setting. Investigators will evaluate clinical practice for AF detection and treatment in stroke patients within large stroke hospital systems of care with multi-ethnic patient populations and thereby representative of the states of Florida and Puerto Rico. The results of this study will be of critical importance for secondary stroke prevention by identifying gaps in stroke care for patients with AF and by recognizing the needs for developing targeted interventions to reduce disparities in diverse populations of stroke patients with AF and improve systems of care for all stroke patients with AF.
Primary Outcome
As measured by modified rankin score (mRS) at discharge (a score that measures the degree of disability or dependence in the daily activities of people who have suffered a stroke). A minimum score of 0 indicates no symptoms and therefore no disability. A maximum score of 6 indicates death has resulted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104,308 participants |
| Start Date | 2010-01-01 |
| Est. Completion | 2021-01-01 |
What the finished NCT03627806 record still lists
NCT03627806 is an observational study that tracks outcomes without assigning an intervention. Its 104,308 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03627806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03627806 about?
NCT03627806 is a clinical study titled "FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)". In this study, FL-PR Stroke Registry will be used to determine novel data on disparities in stroke care and outcomes for patients with Atrial Fibrillation (AF) in 'real life' hospital setting. Investigators will evaluate clinical practice for AF detection and treatment in stroke patients within larg...
What is the current status of trial NCT03627806?
This trial is currently completed. The enrollment target is 104,308 participants. The study started on 2010-01-01. Estimated completion is 2021-01-01.
Who is sponsoring clinical trial NCT03627806?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05804188 · 105,000 participants
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
- NCT02917460 · 102,000 participants · NA
Rady Children's Institute Genomic Biorepository
- NCT05741112 · 100,500 participants · NA
The Long COVID-19 Wearable Device Study
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI